A New Era for Cystic Fibrosis and Cystic Fibrosis Transmembrane Conductance Regulator Modulator Trials in Infants

被引：1

作者：

Wainwright, Claire E. ^{[1
]}

机构：

[1] Univ Queensland, Paediat & Child Hlth, South Brisbane, Qld, Australia

来源：

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2022年 / 206卷 / 10期

关键词：

LUMACAFTOR; IVACAFTOR;

D O I：

10.1164/rccm.202207-1356ED

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

引用

页码：1193 / 1195

页数：4

共 15 条

[1] The future of cystic fibrosis care: a global perspective [J].

Bell, Scott C. ;

Mall, Marcus A. ;

Gutierrez, Hector ;

Macek, Milan ;

Madge, Susan ;

Davies, Jane C. ;

Burgel, Pierre-Regis ;

Tullis, Elizabeth ;

Castaos, Claudio ;

Castellani, Carlo ;

Byrnes, Catherine A. ;

Cathcart, Fiona ;

Chotirmall, Sanjay H. ;

Cosgriff, Rebecca ;

Eichler, Irmgard ;

Fajac, Isabelle ;

Goss, Christopher H. ;

Drevinek, Pavel ;

Farrell, Philip M. ;

Gravelle, Anna M. ;

Havermans, Trudy ;

Mayer-Hamblett, Nicole ;

Kashirskaya, Nataliya ;

Kerem, Eitan ;

Mathew, Joseph L. ;

McKone, Edward F. ;

Naehrlich, Lutz ;

Nasr, Samya Z. ;

Oates, Gabriela R. ;

O'Neill, Ciaran ;

Pypops, Ulrike ;

Raraigh, Karen S. ;

Rowe, Steven M. ;

Southern, Kevin W. ;

Sivam, Sheila ;

Stephenson, Anne L. ;

Zampoli, Marco ;

Ratjen, Felix .

LANCET RESPIRATORY MEDICINE, 2020, 8 (01) :65-124

[2] CFTR-function and ventilation inhomogeneity in individuals with cystic fibrosis [J].

Bernasconi, Nadine ;

Kieninger, Elisabeth ;

Shaw, Michelle ;

Kurz, Johanna ;

Moeller, Alexander ;

Ratjen, Felix ;

Rochat, Isabelle ;

Stanojevic, Sanja ;

Singer, Florian .

JOURNAL OF CYSTIC FIBROSIS, 2021, 20 (04) :641-647

[3] Data from the US and UK cystic fibrosis registries support disease modification by CFTR modulation with ivacaftor [J].

Bessonova, Leona ;

Volkova, Nataliya ;

Higgins, Mark ;

Bengtsson, Leif ;

Tian, Simon ;

Simard, Christopher ;

Konstan, Michael W. ;

Sawicki, Gregory S. ;

Sewall, Ase ;

Nyangoma, Stephen ;

Elbert, Alexander ;

Marshall, Bruce C. ;

Bilton, Diana .

THORAX, 2018, 73 (08) :731-740

[4] A CFTR corrector (lumacaftor) and a CFTR potentiator (ivacaftor) for treatment of patients with cystic fibrosis who have a phe508del CFTR mutation: a phase 2 randomised controlled trial [J].

Boyle, Michael P. ;

Bell, Scott C. ;

Konstan, Michael W. ;

McColley, Susanna A. ;

Rowe, Steven M. ;

Rietschel, Ernst ;

Huang, Xiaohong ;

Waltz, David ;

Patel, Naimish R. ;

Rodman, David .

LANCET RESPIRATORY MEDICINE, 2014, 2 (07) :527-538

[5] Safety, pharmacokinetics, and pharmacodynamics of ivacaftor in patients aged 2-5 years with cystic fibrosis and a CFTR gating mutation (KIWI): an open-label, single-arm study [J].

Davies, Jane C. ;

Cunningham, Steve ;

Harris, William T. ;

Lapey, Allen ;

Regelmann, Warren E. ;

Sawicki, Gregory S. ;

Southern, Kevin W. ;

Robertson, Sarah ;

Green, Yulia ;

Cooke, Jon ;

Rosenfeld, Margaret .

LANCET RESPIRATORY MEDICINE, 2016, 4 (02) :107-115

[6] Cystic fibrosis in the year 2020: A disease with a new face [J].

De Boeck, Kris .

ACTA PAEDIATRICA, 2020, 109 (05) :893-899

[7]

Fayon M, 2016, ARCH PEDIAT, V23, p12S9

[8] Long-term safety of lumacaftor-ivacaftor in children aged 2-5 years with cystic fibrosis homozygous for the F508del-CFTR mutation: a multicentre, phase 3, open-label, extension study [J].

Hoppe, Jordana E. ;

Chilvers, Mark ;

Ratjen, Felix ;

McNamara, John J. ;

Owen, Caroline A. ;

Tian, Simon ;

Zahigian, Rachel ;

Cornell, Alexandra G. ;

McColley, Susanna A. .

LANCET RESPIRATORY MEDICINE, 2021, 9 (09) :977-988

[9] CFTR Modulators: The Changing Face of Cystic Fibrosis in the Era of Precision Medicine [J].

Lopes-Pacheco, Miqueias .

FRONTIERS IN PHARMACOLOGY, 2020, 10

[10] Evolution of Pancreatic Function during the First Year in Infants with Cystic Fibrosis [J].

O'Sullivan, Brian P. ;

Baker, Dawn ;

Leung, Katherine G. ;

Reed, George ;

Baker, Susan S. ;

Borowitz, Drucy .

JOURNAL OF PEDIATRICS, 2013, 162 (04) :808-+

← 1 2 →